INR 193.4
(0.34%)
Year | Net Debt | Net Debt Growth |
---|---|---|
2023 | 18.99 Billion INR | -8.56% |
2022 | 20.77 Billion INR | 20.78% |
2021 | 17.19 Billion INR | 27.83% |
2020 | 13.45 Billion INR | 8.89% |
2019 | 12.35 Billion INR | 27.92% |
2018 | 9.65 Billion INR | -6.16% |
2017 | 10.29 Billion INR | 15.51% |
2016 | 8.91 Billion INR | 0.5% |
2015 | 8.86 Billion INR | -2.38% |
2014 | 9.08 Billion INR | -3.73% |
2013 | 9.43 Billion INR | 12.78% |
2012 | 8.36 Billion INR | 0.77% |
2011 | 8.3 Billion INR | 21.08% |
2010 | 6.85 Billion INR | -5.88% |
2009 | 7.28 Billion INR | 7.57% |
2008 | 6.77 Billion INR | 14.57% |
2007 | 5.91 Billion INR | 12.51% |
2006 | 5.25 Billion INR | 176.08% |
2005 | 1.9 Billion INR | 0.0% |
Year | Net Debt | Net Debt Growth |
---|---|---|
2023 Q1 | - INR | -100.0% |
2023 Q4 | 18.99 Billion INR | 0.0% |
2023 Q2 | 21.2 Billion INR | 0.0% |
2023 Q3 | - INR | -100.0% |
2023 FY | 18.99 Billion INR | -8.56% |
2022 Q3 | - INR | -100.0% |
2022 FY | 20.77 Billion INR | 20.78% |
2022 Q4 | 20.77 Billion INR | 0.0% |
2022 Q1 | - INR | -100.0% |
2022 Q2 | 18.69 Billion INR | 0.0% |
2021 Q3 | - INR | -100.0% |
2021 FY | 17.19 Billion INR | 27.83% |
2021 Q2 | 13.91 Billion INR | 0.0% |
2021 Q1 | - INR | -100.0% |
2021 Q4 | 17.19 Billion INR | 0.0% |
2020 FY | 13.45 Billion INR | 8.89% |
2020 Q2 | 10.59 Billion INR | 0.0% |
2020 Q4 | 13.45 Billion INR | 0.0% |
2019 FY | 12.35 Billion INR | 27.92% |
2019 Q2 | 10.41 Billion INR | 0.0% |
2019 Q4 | 12.35 Billion INR | 0.0% |
2018 FY | 9.65 Billion INR | -6.16% |
2018 Q4 | 9.65 Billion INR | 0.0% |
2018 Q2 | 9.72 Billion INR | 0.0% |
2017 FY | 10.29 Billion INR | 15.51% |
2017 Q2 | 8.97 Billion INR | 0.0% |
2017 Q4 | 10.29 Billion INR | 0.0% |
2016 FY | 8.91 Billion INR | 0.5% |
2016 Q4 | 8.91 Billion INR | 0.0% |
2016 Q2 | 7.42 Billion INR | 0.0% |
2015 FY | 8.86 Billion INR | -2.38% |
2015 Q4 | 8.86 Billion INR | 0.0% |
2015 Q2 | 7.21 Billion INR | 0.0% |
2014 Q2 | 6.73 Billion INR | 0.0% |
2014 FY | 9.08 Billion INR | -3.73% |
2014 Q4 | 9.08 Billion INR | 0.0% |
2013 Q2 | 8.3 Billion INR | 0.0% |
2013 Q4 | 9.43 Billion INR | 0.0% |
2013 FY | 9.43 Billion INR | 12.78% |
2012 FY | 8.36 Billion INR | 0.77% |
2012 Q4 | 8.36 Billion INR | 0.0% |
2011 Q4 | 8.3 Billion INR | 0.0% |
2011 FY | 8.3 Billion INR | 21.08% |
2010 FY | 6.85 Billion INR | -5.88% |
2009 FY | 7.28 Billion INR | 7.57% |
2008 FY | 6.77 Billion INR | 14.57% |
2007 FY | 5.91 Billion INR | 12.51% |
2006 FY | 5.25 Billion INR | 176.08% |
2005 FY | 1.9 Billion INR | 0.0% |
Name | Net Debt | Net Debt Difference |
---|---|---|
Alfavision Overseas (India) Limited | 1.35 Billion INR | -1301.882% |
Biocon Limited | 140.18 Billion INR | 86.451% |
Blue Jet Healthcare Limited | -830.93 Million INR | 2385.692% |
Concord Biotech Limited | -372.86 Million INR | 5193.626% |
FERMENTA BIOTECH LIMITED | 1.1 Billion INR | -1619.678% |
GENOMIC VALLEY BIOTECH LIMITED | -60.73 Thousand INR | 31271710.63% |
Lyka Labs Limited | 527.01 Million INR | -3503.801% |
Panacea Biotec Limited | -1.18 Billion INR | 1702.878% |
SAMSRITA LABS LIMITED | 21.98 Million INR | -86271.632% |
Servoteach Industries Limited | 5016.00 INR | -378638257.257% |
SMS Lifesciences India Limited | 992.31 Million INR | -1813.963% |
Supriya Lifescience Limited | -694.68 Million INR | 2833.993% |
Syngene International Limited | -83 Million INR | 22982.53% |
TAKE Solutions Limited | 361.37 Million INR | -5155.694% |
Titan Biotech Limited | 54.62 Million INR | -34666.969% |
Transgene Biotek Limited | 139.93 Million INR | -13472.567% |
Vanta Bioscience Limited | 607.93 Million INR | -3024.126% |